drugset / Trial / NCT01371968

Optimal Dose of Alfentanil for Removal of Supreme Laryngeal Mask Airway During Emergence From Desflurane Anaesthesia

NCT01371968

NaSingle-groupOpen-labelOther

Summary

This study aims to determine the optimal dose of alfentanil in suppressing the airway reflexes during supreme LMA removal in anaesthetized adult.

Timeline

Start
2011-02
Primary completion
2011-08
Completion
2011-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Alfentanil Other / unclassified Intravenous